132 related articles for article (PubMed ID: 30709604)
21. [Adherence of type 2 diabetes patients on insulin analogues application: missed dose, time imprecision and dose reduction. The results of GAPP2TM(Global Attitudes of Physicians and Patient) survey in the Czech Republic].
Prázný M
Vnitr Lek; 2014 Nov; 60(11):999-1006. PubMed ID: 25600048
[TBL] [Abstract][Full Text] [Related]
22. The perceived barriers to insulin therapy among type 2 diabetic patients.
Hussein A; Mostafa A; Areej A; Mona AM; Shimaa A; Najd AG; Futoon A
Afr Health Sci; 2019 Mar; 19(1):1638-1646. PubMed ID: 31148993
[TBL] [Abstract][Full Text] [Related]
23. Postprandial glucose and healthcare resource use: a cross-sectional survey of adults with diabetes treated with basal-bolus insulin.
Pfeiffer KM; Sandberg A; Nikolajsen A; Brod M
J Med Econ; 2018 Jan; 21(1):66-73. PubMed ID: 28875766
[TBL] [Abstract][Full Text] [Related]
24. How do health care professionals assess patients when initiating insulin therapy? A qualitative study.
Lee PY; Lee YK; Khoo EM; Ng CJ
Prim Care Diabetes; 2014 Apr; 8(1):49-55. PubMed ID: 24315732
[TBL] [Abstract][Full Text] [Related]
25. Primary care physician perspectives on basal insulin initiation and maintenance in patients with type 2 diabetes mellitus.
Kalirai S; Stephenson J; Perez-Nieves M; Grabner M; Hadjiyianni I; Geremakis C; Pollom RD; Reed B; Fisher L
Prim Care Diabetes; 2018 Apr; 12(2):155-162. PubMed ID: 29100717
[TBL] [Abstract][Full Text] [Related]
26. Psychological insulin resistance: patient beliefs and implications for diabetes management.
Brod M; Kongsø JH; Lessard S; Christensen TL
Qual Life Res; 2009 Feb; 18(1):23-32. PubMed ID: 19039679
[TBL] [Abstract][Full Text] [Related]
27. NIDDM patients' fears and hopes about insulin therapy. The basis of patient reluctance.
Hunt LM; Valenzuela MA; Pugh JA
Diabetes Care; 1997 Mar; 20(3):292-8. PubMed ID: 9051375
[TBL] [Abstract][Full Text] [Related]
28. Self-management support for insulin therapy in type 2 diabetes.
Funnell MM; Kruger DF; Spencer M
Diabetes Educ; 2004; 30(2):274-80. PubMed ID: 15095517
[TBL] [Abstract][Full Text] [Related]
29. Attitudes towards insulin pump therapy among adolescents and young people.
Seereiner S; Neeser K; Weber C; Schreiber K; Habacher W; Rakovac I; Beck P; Schmidt L; Pieber TR
Diabetes Technol Ther; 2010 Jan; 12(1):89-94. PubMed ID: 20082590
[TBL] [Abstract][Full Text] [Related]
30. Explaining psychological insulin resistance in adults with non-insulin-treated type 2 diabetes: The roles of diabetes distress and current medication concerns. Results from Diabetes MILES--Australia.
Holmes-Truscott E; Skinner TC; Pouwer F; Speight J
Prim Care Diabetes; 2016 Feb; 10(1):75-82. PubMed ID: 26150327
[TBL] [Abstract][Full Text] [Related]
31. Assessing Psychological Insulin Resistance in Type 2 Diabetes: a Critical Comparison of Measures.
Holmes-Truscott E; Pouwer F; Speight J
Curr Diab Rep; 2017 Jul; 17(7):46. PubMed ID: 28508930
[TBL] [Abstract][Full Text] [Related]
32. Psychological Insulin Resistance in Patients with Type 2 Diabetes.
Jha S; Panda M; Kumar S; Gupta R; Neemani A; Jacob J; Thomas NM; James A; Waghdhare S; Agarwal G
J Assoc Physicians India; 2015 Jul; 63(7):33-9. PubMed ID: 26731825
[TBL] [Abstract][Full Text] [Related]
33. Embracing insulin. It's a miracle drug. So why do so many people with type 2 try to avoid the needle at any cost?
Gebel E
Diabetes Forecast; 2008 Aug; 61(8):45-7. PubMed ID: 18788128
[No Abstract] [Full Text] [Related]
34. Effects of metabolic control, patient education and initiation of insulin therapy on the quality of life of patients with type 2 diabetes mellitus.
Braun A; Sämann A; Kubiak T; Zieschang T; Kloos C; Müller UA; Oster P; Wolf G; Schiel R
Patient Educ Couns; 2008 Oct; 73(1):50-9. PubMed ID: 18583087
[TBL] [Abstract][Full Text] [Related]
35. Initiation of insulin for type 2 diabetes mellitus patients: what are the issues? A qualitative study.
Tan AM; Muthusamy L; Ng CC; Phoon KY; Ow JH; Tan NC
Singapore Med J; 2011 Nov; 52(11):801-9. PubMed ID: 22173249
[TBL] [Abstract][Full Text] [Related]
36. Removing barriers to insulin use.
Minze MG; Dalal K; Irons BK
J Fam Pract; 2011 Oct; 60(10):577-80. PubMed ID: 21977484
[TBL] [Abstract][Full Text] [Related]
37. Physician experiences when discussing the need for additional oral medication with type 2 diabetes patients: Insights from the cross-national IntroDia® study.
Down S; Alzaid A; Polonsky WH; Belton A; Edelman S; Gamerman V; Nagel F; Lee J; Emmerson J; Capehorn M
Diabetes Res Clin Pract; 2019 Feb; 148():179-188. PubMed ID: 30641173
[TBL] [Abstract][Full Text] [Related]
38. Basal insulin initiation use and experience among people with type 2 diabetes mellitus with different patterns of persistence: results from a multi-national survey.
Perez-Nieves M; Ivanova JI; Hadjiyianni I; Zhao C; Cao D; Schmerold L; Kalirai S; King S; DeLozier AM; Birnbaum HG; Peyrot M
Curr Med Res Opin; 2017 Oct; 33(10):1833-1842. PubMed ID: 28604111
[TBL] [Abstract][Full Text] [Related]
39. Overcoming psychological insulin resistance: A practical guide for healthcare professionals.
Snoek FJ; Fisher L; Polonsky WH; Stuckey H; Hessler D; Tang T; Hermanns N; Mundet X; Silva M; Sturt J; Okazaki K; Hadjiyianni I; Desai U; Perez-Nieves M
Prim Care Diabetes; 2021 Jun; 15(3):619-621. PubMed ID: 33785288
[TBL] [Abstract][Full Text] [Related]
40. Management of severe hypoglycaemia: cultural similarities, differences and resource consumption in three European countries.
Lammert M; Hammer M; Frier BM
J Med Econ; 2009; 12(4):269-80. PubMed ID: 20001569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
